News and Announcements
Proteomics International Expands Diagnostics Portfolio to Endometriosis
- Published August 24, 2016 10:56AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
24th August 2016, ASX Announcement
Life sciences company Proteomics International Laboratories Ltd (PILL, ASX: PIQ) is applying its disruptive proteomics technology platform to new areas of significant unmet medical need.
- PILL is investigating protein ‘fingerprints’ that can diagnose endometriosis from a simple blood test.
- Endometriosis affects one in ten women in their reproductive years and costs Australia $7.7 billion annually.
- The research employs PILL’s proven Promarker platform, which has already been used to develop a predictive test for diabetic kidney disease, and could deliver results within 12 months.
Perth company PILL is investigating proteins in the blood that are associated with endometriosis, paving the way for the development of a quick and easy diagnostic test for the painful condition.
Endometriosis occurs when the tissues that line the uterus spread and surround other organs. The condition affects one in ten women in their reproductive years (15-49) and costs $12,000 per year for every person diagnosed – both incidence and health burden are comparable with diabetes.
To view the full announcement, please click on the button below.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
